CECOG Academy Podcasts

5. CECOG - Fireside Chats - Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment

April 30, 2021 CECOG - Central European Cooperative Oncology Group Season 2 Episode 5
5. CECOG - Fireside Chats - Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment
CECOG Academy Podcasts
More Info
CECOG Academy Podcasts
5. CECOG - Fireside Chats - Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment
Apr 30, 2021 Season 2 Episode 5
CECOG - Central European Cooperative Oncology Group

Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment

Host: Doz. Dr. Christiane Thallinger

Univ. Prof. Dr. Evandro De Azambuja

Institut Jules Bordet
Belgium

Univ. Prof. Dr. Christoph Zielinski

Professor of Medical Oncology and Clinical Immunology
Medical Director, Wiener Privatklinik and Central European Cancer Center
Wien, Austria
President, Central European Cooperative Oncology Group (CECOG)
Editor in Chief, "ESMO Open - Cancer Horizons", 2016-2021

Show Notes

Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment

Host: Doz. Dr. Christiane Thallinger

Univ. Prof. Dr. Evandro De Azambuja

Institut Jules Bordet
Belgium

Univ. Prof. Dr. Christoph Zielinski

Professor of Medical Oncology and Clinical Immunology
Medical Director, Wiener Privatklinik and Central European Cancer Center
Wien, Austria
President, Central European Cooperative Oncology Group (CECOG)
Editor in Chief, "ESMO Open - Cancer Horizons", 2016-2021